These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28484970)

  • 41. Behavioural effects of some 4-substituted amphetamines.
    Beaton JM; Smythies JR; Benington F; Morin RD; Clark LC
    Nature; 1968 Nov; 220(5169):800-1. PubMed ID: 5698757
    [No Abstract]   [Full Text] [Related]  

  • 42. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.
    Butelman ER; Harris TJ; Kreek MJ
    Psychopharmacology (Berl); 2004 Mar; 172(2):220-4. PubMed ID: 14586540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Electrographic and behavioral effects of various hallucinogens in the free cat].
    Rougeul A; Verdeaux J; Letalle A
    Rev Neurol (Paris); 1969 Jun; 120(6):391-4. PubMed ID: 5379317
    [No Abstract]   [Full Text] [Related]  

  • 44. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
    Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of marsilin on the behavioural and other changes in the central nervous system induced by psychotropic drugs.
    Dey PK; Chatterjee BK
    Indian J Exp Biol; 1966 Apr; 4(2):99-100. PubMed ID: 5942509
    [No Abstract]   [Full Text] [Related]  

  • 46. The stimulus effects of serotonergic hallucinogens in animals.
    Winter JC
    NIDA Res Monogr; 1994; 146():157-82. PubMed ID: 8742798
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.
    Doat-Meyerhoefer MM; Hard R; Winter JC; Rabin RA
    Pharmacol Biochem Behav; 2005 Aug; 81(4):750-7. PubMed ID: 15972234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationships among hallucinogenic tryptamine derivatives evaluated by schedule-controlled behaviour.
    Harris RA; Homfeld E; Campaigne E
    J Pharm Pharmacol; 1981 May; 33(5):320-2. PubMed ID: 6116783
    [No Abstract]   [Full Text] [Related]  

  • 49. An ethologic search for self-administration of hallucinogens.
    Siegel RK
    Int J Addict; 1973; 8(2):373-93. PubMed ID: 4585053
    [No Abstract]   [Full Text] [Related]  

  • 50. Examination of the hallucinogen 2,5-dimethoxy-4-methylamphetamine.
    Phillips GF; Mesley RJ
    J Pharm Pharmacol; 1969 Jan; 21(1):9-17. PubMed ID: 4388198
    [No Abstract]   [Full Text] [Related]  

  • 51. Similarities and differences between behavioral control by drug-produced stimuli and by sensory stimuli.
    Overton DA
    Psychopharmacol Ser; 1988; 4():176-98. PubMed ID: 3293042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical factors influencing the psychotomimetic potency of glycolate esters.
    Baumgold J; Abood LG; Hoss WP
    Life Sci; 1975 Aug; 17(4):603-11. PubMed ID: 1186427
    [No Abstract]   [Full Text] [Related]  

  • 53. [Study of the neurologic and psychopathologic effects of a new drug with psychotomimetic action (JB-329 or Ditran) in depressed patients].
    GIBERTI F; ROCCATAGLIATA G; ROSSI R
    Sist Nerv; 1961; 13():167-75. PubMed ID: 13898382
    [No Abstract]   [Full Text] [Related]  

  • 54. Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models.
    Volgin AD; Yakovlev OA; Demin KA; Alekseeva PA; Kyzar EJ; Collins C; Nichols DE; Kalueff AV
    ACS Chem Neurosci; 2019 Jan; 10(1):143-154. PubMed ID: 30252437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The stimulants and hallucinogens under consideration: a brief overview of their chemistry and pharmacology.
    Harris LS
    Drug Alcohol Depend; 1986 Jun; 17(2-3):107-18. PubMed ID: 2874966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.
    Stolerman IP; Shine PJ
    Psychopharmacology (Berl); 1985; 86(1-2):1-11. PubMed ID: 2862655
    [No Abstract]   [Full Text] [Related]  

  • 57. Intrinsic activity and discriminative effects of drugs.
    Colpaert FC
    Psychopharmacol Ser; 1988; 4():154-60. PubMed ID: 3293040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [RECENT PROGRESS IN RESEARCH IN PSYCHOTROPIC DRUGS: THE PSYCHOTOMIMETIC ACTION OF BENZOQUINOLIZINE AND PIPERIDYL GLYCOLATES AND THEIR STRUCTURE ACTIVITY RELATIONSHIPS].
    FU NW
    Yao Xue Xue Bao; 1964 Jul; 11():497-508. PubMed ID: 14202494
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical experiences with a new hallucinogen with atropine-like effect].
    SCHULTZE F
    Med Exp Int J Exp Med; 1960; 2():233-6. PubMed ID: 14443809
    [No Abstract]   [Full Text] [Related]  

  • 60. Behavioral and arterial pressure effects of pimetine in conscious dogs.
    Karol B; Brown ML; Sletten IW
    Eur J Pharmacol; 1967 Jul; 1(4):342-6. PubMed ID: 6082309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.